CARDIOLOGY, published by KARGER, is a renowned scholarly journal dedicated to the advancement of research in the fields of cardiology and cardiovascular medicine. Since its inception in 1937, the journal has consistently provided a platform for high-quality, peer-reviewed articles that contribute to the understanding and treatment of heart and vascular diseases. With an impressive convergence through 2024, CARDIOLOGY holds a respectable Q2 ranking in both the Cardiology and Cardiovascular Medicine and Pharmacology (medical) categories, placing it within the 53rd and 45th percentiles of respective Scopus ranks. Based in Switzerland, the journal serves as an essential resource for researchers and practitioners aiming to stay abreast of cutting-edge developments and evidence-based practices in cardiovascular health. While it currently does not offer open access options, its commitment to rigorous scientific standards solidifies its significance within the academic community. We invite readers to explore the latest research findings and contribute to this vital field through publications in CARDIOLOGY.

Journal of Stroke & Cerebrovascular Diseases, published by ELSEVIER, is a leading international peer-reviewed journal dedicated to advancing the research and understanding of stroke and cerebrovascular disorders. With an impressive impact factor reflective of its rigorous academic standards, this journal is indexed in the highest echelons of medical disciplines, boasting a Q1 classification in Rehabilitation and prominent rankings in related fields. Established in 1991 and converging its focus toward 2024, it serves as a vital resource for researchers and clinicians interested in the complexities and treatment of cerebrovascular conditions. The journal's broad scope spans essential categories such as cardiology, neurology, and surgery, making significant contributions that enhance clinical practices and patient outcomes. For researchers, professionals, and students alike, the Journal of Stroke & Cerebrovascular Diseases is not just a publication but a critical platform for sharing innovative findings and fostering impactful discussions within the medical community.

NEUROIMAGING CLINICS OF NORTH AMERICA is a premier peer-reviewed journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on the evolving field of neuroimaging and its applications in clinical practice. Established in 1993, this journal has become a pivotal resource for researchers, professionals, and students alike, providing in-depth articles, reviews, and case studies that address both cutting-edge advancements and standard practices in neuroimaging. With its impressive credentials, ranking in the top quartiles of various medical categories—including Q2 in Medicine (Miscellaneous) and Q2 in Radiology, Nuclear Medicine, and Imaging—the journal is vital for advancing knowledge and clinical applications in the disciplines of neurology and radiology. Although it does not offer open access, the journal maintains a robust reputation with a broad readership, embodying a commitment to excellence in medical literature. The ISSN number is 1052-5149 and the E-ISSN number is 1557-9867, ensuring the accessibility and dissemination of high-quality neuroimaging research.

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

The Journal of Neurological Surgery Part A – Central European Neurosurgery is a prominent peer-reviewed publication dedicated to advancing the field of neurosurgery and its related disciplines. Published by THIEME MEDICAL PUBL INC and based in Germany, this journal has been a platform for critical advancements in clinical neurology and surgery since its inception in 2012, and it is set to continue through 2024. With a current impact factor reflecting its influence in the medical community, the journal ranks in the Q3 quartile across the categories of Medicine (miscellaneous), Neurology (clinical), and Surgery for 2023, ensuring a robust participation from the academic and medical professionals alike. It is indexed in Scopus, highlighting its global recognition, with rankings of #248/551 and #257/400 in the fields of Medicine & Surgery and Neurology, respectively. The journal features a range of open access options, thereby facilitating unrestricted dissemination of high-quality research to a wide audience. As a valuable resource, it aims to promote the exchange of innovative ideas and research findings that can contribute to clinical practice and improve patient outcomes in neurosurgery.

NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.

The Journal of NeuroInterventional Surgery, published by the BMJ Publishing Group, stands at the forefront of advancing knowledge in the fields of neurointerventional procedures, neurology, and surgical techniques. With an impressive impact factor reflective of its high-quality contributions, this journal occupies a prestigious position within the Q1 category across multiple domains: Medicine (miscellaneous), Neurology (clinical), and Surgery, ranking 11th in Medicine Surgery and 47th in Neurology Clinical out of their respective categories per Scopus metrics. Since its inception in 2009, it has provided an essential platform for researchers, clinicians, and students to disseminate innovative findings and engage with groundbreaking developments in neurointerventional practices. As a prominent publication in the United Kingdom, located at British Med Assoc House, it is committed to open communication within the community, fostering collaboration, and setting the stage for future innovations in patient care and outcomes.

INTERVENTIONAL NEURORADIOLOGY, published by SAGE PUBLICATIONS INC, is a key journal within the interdisciplinary fields of cardiology, neurology, and radiology, focusing on the latest advancements and clinical practices in neuroradiology. With an ISSN of 1591-0199 and an E-ISSN of 2385-2011, this journal has established itself as a vital resource since its inception in 1996, attracting contributions from leading experts worldwide. Currently categorized in the Q2 category for Cardiology and Cardiovascular Medicine and Radiology, and Q3 for Clinical Neurology as of 2023, INTERVENTIONAL NEURORADIOLOGY has gained recognition for its impactful research, reflected in its ranking within the Scopus metrics. Although not an open-access publication, its rigorous peer-reviewed articles provide indispensable knowledge that enhances the practice and understanding of interventional procedures. Researchers, clinicians, and students will find this journal a valuable avenue for insights into the evolving landscape of neuroradiological interventions, ultimately contributing to improved patient outcomes.

ANNALS OF NEUROLOGY, published by Wiley, stands as a leading journal in the field of neurology, renowned for its rigorous peer-reviewed articles that contribute significantly to the understanding of neurological disorders and advances in clinical practices. With an impressive impact factor and ranked Q1 in both neurology and clinical neurology categories, this journal positions itself among the top repositories of cutting-edge research, indexed in Scopus with exemplary ranks in the 98th and 97th percentiles respectively. Since its inception in 1977 and with a commitment to excellence extending to 2024 and beyond, ANNALS OF NEUROLOGY aims to disseminate groundbreaking studies and foster dialogue within the academic community, making it an essential resource for researchers, healthcare professionals, and students dedicated to neurology. Although it does not currently offer open access, its accessibility through institutional subscriptions facilitates widespread scholarly engagement.

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.